Evaluation of Chiglitazar Sodium With Lifestyle Intervention for Reversing Prediabetes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Quanzhou First Hospital, Fujian
Quanzhou, Fujian, China
- the First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
- the First Hospital of Harbin
Harbin, Heilongjiang, China
Binhua Xu, MD, M.M. - the Second Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Hong Qiao, MD, PhD - the First Affiliated Hospital of Henan University of Science & Technology
Luoyang, Henan, China
- Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China
Zhe Dai, MD, PhD - the First People'S Hospital of Changde City
Changde, Hunan, China
- Changsha Eighth Hospital
Changsha, Hunan, China
- People'S Hospital of Hunan Province
Changsha, Hunan, China
- the Second Xiangya Hospital, Central South University
Changsha, Hunan, China
Chuqing Cao, MD, PhDZhiguang Zhou, MD, PhD - the Third Xiangya Hospital of Central South University
Changsha, Hunan, China
- Loudi Central Hospital
Loudi, Hunan, China
- the Central Hospital of Xiangtan
Xiangtan, Hunan, China
- the Central Hospital of Yongzhou
Yongzhou, Hunan, China
- Yueyang People'S Hospital
Yueyang, Hunan, China
- Sir Run Run Hospital, Nanjing Medical University
Nanjing, Jiangsu, China
- Heji Hospital Affiliated To Changzhi Medical College
Changzhi, Shanxi, China
- Chengdu First People'S Hospital
Chengdu, Sichuan, China
Lin Pu, MD,M.M. - Sichuan Academy of Medical Sciences & Sichuan Provincial People'S Hospital
Chengdu, Sichuan, China
Limin Tian, MD,PhD - the Third People'S Hospital of Chengdu
Chengdu, Sichuan, China
Xiaowei Zhong, MD,PhD - the First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
- the Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
- Beijing Tsinghua Changgung Hospital
Beijing, China
- Emergency General Hospital
Beijing, China
- Xuanwu Hospital Capital Medical University
Beijing, China
YU Sun, MD, PhD - the Southwest Hospital of the Army Medical University
Chongqing, China
Min Long, MD, PhD - Shanghai Ninth People'S Hospital
Shanghai, China
- Tongji Hospital of Tongji University
Shanghai, China
- Shenzhen Bao'An People'S Hospital
Shenzhen, China
- Shenzhen Bao'An Traditional Chinese Medicine Hospital
Shenzhen, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Apr 2026
- Primary completion
- 31 Dec 2028
- Completion
- 31 Dec 2029
- Last update posted
- 30 Apr 2026
- Registered enrollment
- 472
- Registry id
- NCT07558525
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.